Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancer

This publication has 15 references indexed in Scilit:

• Hypersensitivity reactions to CHIP.
  Journal of Clinical Oncology, 1990
• A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.
  Journal of Clinical Oncology, 1990
• A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP
  Cancer Chemotherapy and Pharmacology, 1990
• Phase II Study of Carboplatin in Locally Advanced and Metastatic Transitional Cell Carcinoma of the Urinary Bladder
  British Journal of Urology, 1989
• Iproplatin and carboplatin induced toxicities: Overview of phase II clinical trial conducted by the EORTC early clinical trials cooperative group (ECTG)
  European Journal of Cancer and Clinical Oncology, 1988
• A phase II study of carboplatin in metastatic transition cell carcinoma of the bladder
  European Journal of Cancer and Clinical Oncology, 1987
• Combination Chemotherapy with Cisplatin and Methotrexate in Advanced Transitional Cell Cancer of the Bladder
  Journal of Urology, 1987
• Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II
  Cancer Chemotherapy and Pharmacology, 1982
• Nephrotoxicity of cis‐platinum (II) dichlorodiammine
  Clinical Pharmacology & Therapeutics, 1978
• The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent
  Journal of Chronic Diseases, 1961